SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-20-021546
Filing Date
2020-05-06
Accepted
2020-05-06 07:45:32
Documents
2
Period of Report
2020-05-05
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K nltx-8k_20200506.htm 8-K 68874
2 EX-10.1 nltx-ex101_6.htm EX-10.1 80032
  Complete submission text file 0001564590-20-021546.txt   150248
Mailing Address SUITE 360 - 1616 EASTLAKE AVE EAST SEATTLE WA 98102
Business Address SUITE 360 - 1616 EASTLAKE AVE EAST SEATTLE WA 98102 206-732-2133
Neoleukin Therapeutics, Inc. (Filer) CIK: 0001404644 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36327 | Film No.: 20851171
SIC: 2834 Pharmaceutical Preparations